Employer Perspectives on a Specialty Drug Step-Therapy Program Evaluation
Am Health Drug Benefits
.
2016 Sep;9(6):319-321.
Authors
Matthew Harman
1
,
F Randy Vogenberg
2
Affiliations
1
Director, Clinical Pharmacy Strategies, Employers Health, Columbus, OH.
2
Strategic Advisor and Co-Project Leader, Midwest Business Group on Health National Employer Biologics & Specialty Drug Initiative, Chicago, IL, and Partner, Access Market Intelligence, Greenville, SC.
PMID:
27924185
PMCID:
PMC5123651
No abstract available